Allspring Global Investments
TARS icon

Allspring Global Investments’s Tarsus Pharmaceuticals TARS Stock Holding History

Allspring Global Investments’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.94M Sell
130,329
-1,283
-1% -$82K 0.01% 786
2026
Q1 		$9.24M Buy
131,612
+1,232
+0.9% +$86.1K 0.02% 712
2025
Q4 		$10.5M Buy
130,380
+1,643
+1% +$123K 0.02% 690
2025
Q3 		$7.38M Sell
128,737
-3,825
-3% -$188K 0.01% 793
2025
Q2 		$5.37M Sell
132,562
-36,159
-21% -$1.63M 0.01% 874
2025
Q1 		$8.67M Sell
168,721
-12,401
-7% -$613K 0.02% 768
2024
Q4 		$10M Sell
181,122
-29,409
-14% -$1.34M 0.02% 759
2024
Q3 		$6.92M Buy
210,531
+29,465
+16% +$828K 0.01% 863
2024
Q2 		$4.92M Sell
181,066
-11,237
-6% -$378K 0.01% 954
2024
Q1 		$6.99M Buy
192,303
+4,889
+3% +$144K 0.01% 867
2023
Q4 		$3.8M Sell
187,414
-58,558
-24% -$978K 0.01% 1020
2023
Q3 		$4.37M Buy
245,972
+237,445
+2,785% +$4.2M 0.01% 1005
2023
Q2 		$154K Sell
8,527
-2,005
-19% -$31.9K ﹤0.01% 1895
2023
Q1 		$132K Sell
10,532
-105
-1% -$1.54K ﹤0.01% 1939
2022
Q4 		$156K Sell
10,637
-46
-0.4% -$761 ﹤0.01% 1905
2022
Q3 		$182K Sell
10,683
-1,177
-10% -$18.7K ﹤0.01% 1852
2022
Q2 		$173K Sell
11,860
-900
-7% -$13.5K ﹤0.01% 1859
2022
Q1 		$214K Sell
12,760
-125
-1% -$2.32K ﹤0.01% 2553
2021
Q4 		$289K Buy
+12,885
New +$335K ﹤0.01% 2526

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Allspring Global Investments's TARS Position: Q2 2026 in Review

Allspring Global Investments reduced its Tarsus Pharmaceuticals (TARS) stake by 0.97% in Q2 2026, selling an estimated $82K and leaving 130,329 shares worth $7.94M. The position accounts for 0.01% of the portfolio, ranked #786.

Allspring Global Investments first reported a position in TARS in Q4 2021 and has held it in 19 quarters since. The position peaked at $10.5M in Q4 2025. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Allspring Global Investments held 130,329 shares of Tarsus Pharmaceuticals worth $7.94M as of Q2 2026.
  • Allspring Global Investments sold 1,283 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $82K.
  • Tarsus Pharmaceuticals made up 0.01% of Allspring Global Investments's portfolio in Q2 2026, its #786 holding.
  • Allspring Global Investments first reported a position in Tarsus Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • Allspring Global Investments's Tarsus Pharmaceuticals position peaked at $10.5M in Q4 2025.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.